Wealth Quarterback’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
Wealth Quarterback's BMY Position: Q1 2026 in Review
Wealth Quarterback reduced its Bristol-Myers Squibb (BMY) stake by 17% in Q1 2026, selling an estimated $333K and leaving 27,102 shares worth $1.64M. The position accounts for 0.65% of the portfolio, ranked #36.
Wealth Quarterback first reported a position in BMY in Q4 2019 and has held it in 12 quarters since. The position peaked at $1.77M in Q4 2025. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Wealth Quarterback held 27,102 shares of Bristol-Myers Squibb worth $1.64M as of Q1 2026.
- Wealth Quarterback sold 5,720 Bristol-Myers Squibb shares in Q1 2026, an estimated $333K.
- Bristol-Myers Squibb made up 0.65% of Wealth Quarterback's portfolio in Q1 2026, its #36 holding.
- Wealth Quarterback first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 12 quarters since.
- Wealth Quarterback's Bristol-Myers Squibb position peaked at $1.77M in Q4 2025.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Wealth Quarterback's 13F filing for Q1 2026, filed 9 Apr 2026.